Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway

Fig. 1

PAK4 is upregulated in cervical cancer specimens and associates with poor overall survival. a Upregulated PAK4 mRNA level in the intra-tumor specimens than in the peritumor specimens of cervical cancer patients, with paired t test; b Increased PAK4 mRNA level in cervical cancer specimens, with unpaired t test; c Kaplan-Meier survival analysis for high PAK4 expression level (>1) versus low PAK4 expression level (≤1) in patients with cervical cancer. Statistical significance was considered when p < 0.05

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us